Key result
TRPM4 channel dysregulation drives key cardiovascular pathophysiologies, including arrhythmia, hypertrophy, and ischemia-reperfusion injury.
This review highlights the role of the TRPM4 channel in cardiovascular physiology and pathophysiology, including its involvement in cardiac conduction disease and ischemia-reperfusion injury.
Answers are grounded in this paper and cite their sources.
TRPM4 dysregulation may contribute to arrhythmia and hypertrophy; leaves open therapeutic targeting pending interventional studies.
The transient receptor potential cation channel subfamily M member 4 (TRPM4) channel influences calcium homeostasis during many physiological activities such as insulin secretion, immune response, respiratory reaction, and cerebral vasoconstriction. This calcium-activated, monovalent, selective cation channel also plays a key role in cardiovascular pathophysiology; for example, a mutation in the TRPM4 channel leads to cardiac conduction disease. Recently, it has been suggested that the TRPM4 channel is also involved in the development of cardiac ischemia-reperfusion injury, which causes myocardial infarction. In the present review, we discuss the physiological function of the TRPM4 channel, and assess its role in cardiovascular pathophysiology.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted a review in Cardiovascular diseases. TRPM4 channel was evaluated. The TRPM4 channel is a crucial calcium-activated regulator of monovalent cations, and its dysregulation is fundamentally involved in cardiovascular pathophysiologies including arrhythmia, cardiac hypertrophy, and ischemia-reperfusion injury.
Synapse has enriched 10 related papers. Consider them for comparative context: